Hepatitis drugs save money in long run We cannot have sustainable medical innovation in America without prices that the health care system can sustain. Because the cost of health insurance is fundamentally a reflection of the price of health care services, the excessive price of Sovaldi unavoidably puts upward pressure on premiums for everyone with private coverage. Drug makers have long used monopolies to inflate prices. Until now, policymakers and stakeholders have looked the other way as specialty drug prices have gone higher and higher. -- Health care experts recently gathered at the Centers for Disease Control and Prevention in Atlanta to discuss the public health crisis of hepatitis C, which is ravaging communities across America, and the budding hope that we may soon be able to eliminate it with a prescription medicine called Sovaldi.